Clinical Trial: Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive to BCG Therapy

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972615) titled 'Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive to BCG Therapy' on April 18.

Brief Summary: interventional study of intravesical chemotherapy and sistemic immunotherapy in NMIBC

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Non Muscle Invasive Bladder Cancer

Intervention: DRUG: intravesical Chemotherapy docetaxel/gemcitabine

intravesical quimiotherapy plus intravenous immunotherapy

Recruitment Status: NOT_YET_RECRUITING

Sponsor: BLATAM

Published by HT Digital Content Services with permission from Health Daily Digest....